Member Info for beinthelead

Back in the bin. Ridiculous account. Posts to be reported.

Wyn - a few things you believe on AffiDX;

- Price point is too high
- Little-to-zero sales
- Missed the only opportunity
- Mass testing is not economic, therefor believe it won’t happen

It would be best people refrain from engaging with this continued disruption. It’s sport and very odd.

Do you know when this was last updated?

It’ll be back.

I’m aware that the Twitter handle ‘The Bishop’ has been reported and tweets sent to the relevant authorities. There’s an axe to grind, then there’s false info that is designed (and will) make people lose money. Disgraceful behaviour.

Apologies if posted…

John King has been appointed as Financial Director in October, for the following;

Medusa Healthcare Ltd
Medusa 19 Ltd
Saturn Passport Ltd

I’m hopeful he’ll need those extra digits on the calculator.

Rampers, regardless of what pedestals said you put them on, don’t influence these spikes. It’s GDR Money. It was ABDX money last month. Rinse and repeat.

Yes, I have no problem with my words.

Damp squib in context of AS’s ramps. Absolutely. Sales at scale have not happened. Will they? I believe so. I’ve held, and still hold onto using tests to enable. This is why HUA is pivotal. Look at football matches - I and many mentioned this last year.

Before you do, don’t use the cost of testing argument and who will pick it up. Going forward, the individual will pick it up when the governments stop paying.

Again, agree or not, I do not want the debate; testing to enable via HU is the future. My view. My investment case.

I will not ram and argue this relentlessly against others that disagree. That’s in effect what you’re doing - its boring.

Jeez, Wyn. What exactly are you looking for? Are you really looking for everyone/anyone to sit and bash Avacta with you? I’ll give you a heads up, you’ll get one participant.

AS ramped the LFT. The LFT, to date has been a damp squib in terms of sales aligned to Avacta’s projections. Let’s look forward please.

Or just very clever marketing?

My belief is that this is a clever way of saying their test detects the Spike protein, and not the N.

“ The proprietary Know Now® test, detects the spike protein to the virus (not the nucleocapsid protein as with all other lateral flow antigen tests) and this spike is only apparent on live virus, therefore the test only identifies those people with current infection. It is a true infectivity test.”

Chill Olly - it’ll be fine.

Our test is likely to work, just as it did with delta, which we validated against. Don’t forget, delta had mutations in the n and s areas. We will, and should validate against Omicron.

Sorry Doggy, I hadn’t seen it. Wasn’t looking for a discussion :)

?

Just another troll that’s like a fly in you ear.

We said the same about Jupiter at 160p. They’ve done well so far. Shorting is despicable in my view, but it makes the market.

We’re a sitting duck at the moment and trending the wrong way, hence why we’re attracting the bottom feeders. Avacta has it within their gift (somewhat) to change that over the next few weeks. Comm’s need to improve dramatically. I believe they will, and will in turn drive the SP in the right direction.

Until then, it’s worthless researching shorters, they’re best ignored and let them company do what investors expect it to.

With respect, Avacta’s next growth phase will be tangible, not driven by sentiment and rumour as what drove us past £2.90. Not selling at this stage was a the biggest/riskiest hedge most holders have made to date. No government contract or sales in line with AS’s ramps promoted the fall.

Avacta’s next significant move north will be on the back of AVA, which will be valued way more than £1.65bn.

In summary, £25 is achievable on a successful AVA.

It’s chaos until news. Twitter is now a cesspit of shorters that are using the platform aid their position. Like it or not, they are influential.

News of significant value required. Until then, it’s a play thing for those that are inclined.

How much stock do you now own?

Which bit?

Nice Poirot. Assume they worked together at Leeds, too. Be nice to see these connections paying dividends.